Friday, September 09, 2022 2:44:36 PM
New York Yankees and Duke Basketball
Recent BDSX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:06:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:06:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:04:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:04:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/09/2024 08:07:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/09/2024 08:06:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/09/2024 08:06:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/09/2024 08:04:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:10:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:05:16 PM
- Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management • Business Wire • 05/08/2024 08:01:00 PM
- Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference • Business Wire • 05/07/2024 10:00:00 AM
- Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 • Business Wire • 04/24/2024 10:00:00 AM
- Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting • Business Wire • 04/09/2024 09:00:00 PM
- Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement • Business Wire • 04/05/2024 11:17:00 AM
- Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center • Business Wire • 03/25/2024 10:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/01/2024 11:11:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 11:05:11 AM
- Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights • Business Wire • 03/01/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:17:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:16:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:16:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:15:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:15:29 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM